Anal fistula incidence higher in diabetic patients; current management strategies may be suboptimal

This narrative review examined the pathophysiological mechanisms and clinical management of type 2 diabetes mellitus complicated by cryptoglandular anal fistula. The review did not report specific study design details, sample size, intervention, comparator specifics beyond 'general population guidelines,' or follow-up duration. The analysis found anal fistula incidence is 1.81 to 2.01 times higher in diabetic patients compared to the general population. Diabetic patients also face elevated risks of postoperative infection, delayed healing, and recurrence, which are linked to poor preoperative glycemic control.

Safety and tolerability data, including adverse events and discontinuations, were not reported in the review. The authors note a significant limitation: current management strategies are mostly extrapolated from guidelines developed for the general population. These strategies may fail to address the unique metabolic, immune, and microcirculatory abnormalities present in diabetic patients, potentially leading to suboptimal clinical outcomes.

The review highlights a gap in evidence-based, tailored management for this specific patient subgroup. While it identifies increased risk and potential shortcomings of current practice, it does not propose or evaluate specific alternative interventions. Funding sources and author conflicts of interest were not reported. The findings suggest a need for more targeted research but do not provide definitive guidance for altering current clinical management protocols.